PEGylated Magnetic Liposomes
| Catalog Number | BL-0000079 |
| Description | PEG reserved irreplaceable advantages for liposome modification due to its low toxicity, non-antigenicity, good amphiphilicity and biocompatibility approved by the FDA. PEG modification consists of targeting properties that can prolong the half-life of magnetic liposomes, improve stability in circulation, and alter biological distributions of magnetic liposomes. |
| Appearance | Translucent liquid; PEGylated magnetic liposomes are packaged in amber vials; No sedimentation in the bottom of the vial usually due to liposomes' small sizes. |
| Shelf Life | It is recommended to use products within 4 months of manufacturing date. |
| Storage | PEGylated Magnetic Liposomes should be kept in the dark and refrigerated at 4°C to avoid liposome hydrolysis and NEVER be frozen. |
| Shipping | All liposome-based formulations are shipped in insulated packaging on blue ice at 4°C using overnight shipping or international express shipping. |
| Liposome Concentration | 1,2-dipalmitoyl-sn-glycero-3-phosphocholine: Cholesterol: PEG(2000) : DMPE-DTPA-Gd (37:33:5:25) (molar ratio percentage) |
| Mean Particle Size | 100 nm |
| Buffer | Defaulted with phosphate-buffered saline; Other buffers or deionized water can be provided according to your needs. |
| pH | 7.4 |
| Note | Magnetic liposomes should not be frozen; Ice crystals that form in lipid membranes can rupture membranes and change the size of liposomes, leading to encapsulated drug release and limiting overall effectiveness. Magnetic liposomes should always be stored in the dark at 4°C unless restored from room temperature for brief periods before animal dosing. |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry